Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
Q Zhao, ZE Wu, B Li, F Li - Pharmacology & Therapeutics, 2022 - Elsevier
Small molecule tyrosine kinase inhibitors (TKIs) are widely used as anticancer drugs
approved by US FDA. However, the toxicities of TKIs to multiple organs have greatly limited …
approved by US FDA. However, the toxicities of TKIs to multiple organs have greatly limited …
Cardio-oncology: mechanisms, drug combinations, and reverse cardio-oncology
Z Liang, Y He, X Hu - International Journal of Molecular Sciences, 2022 - mdpi.com
Chemotherapy, radiotherapy, targeted therapy, and immunotherapy have brought hope to
cancer patients. With the prolongation of survival of cancer patients and increased clinical …
cancer patients. With the prolongation of survival of cancer patients and increased clinical …
Characterization and validation of a human 3D cardiac microtissue for the assessment of changes in cardiac pathology
CR Archer, R Sargeant, J Basak, J Pilling, JR Barnes… - Scientific reports, 2018 - nature.com
Pharmaceutical agents despite their efficacy to treat disease can cause additional unwanted
cardiovascular side effects. Cardiotoxicity is characterized by changes in either the function …
cardiovascular side effects. Cardiotoxicity is characterized by changes in either the function …
[HTML][HTML] Traditional Chinese medicine enhances myocardial metabolism during heart failure
W Shao-Mei, Y Li-Fang, W Li-Hong - Biomedicine & Pharmacotherapy, 2022 - Elsevier
The prognosis of various cardiovascular diseases eventually leads to heart failure (HF). An
energy metabolism disorder of cardiomyocytes is important in explaining the molecular …
energy metabolism disorder of cardiomyocytes is important in explaining the molecular …
Efficacy and safety of l‐Carnitine treatment for chronic heart failure: a meta‐analysis of randomized controlled trials
X Song, H Qu, Z Yang, J Rong, W Cai… - BioMed Research …, 2017 - Wiley Online Library
Background. Whether additional benefit can be achieved with the use of L‐carnitine (L‐C) in
patients with chronic heart failure (CHF) remains controversial. We therefore performed a …
patients with chronic heart failure (CHF) remains controversial. We therefore performed a …
Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP)
AFG Cicero, A Colletti, S von Haehling… - Nutrition research …, 2020 - cambridge.org
Heart failure (HF) is a complex clinical syndrome that represents a major cause of morbidity
and mortality in Western countries. Several nutraceuticals have shown interesting clinical …
and mortality in Western countries. Several nutraceuticals have shown interesting clinical …
The nutraceutical value of carnitine and its use in dietary supplements
A Durazzo, M Lucarini, A Nazhand, SB Souto, AM Silva… - Molecules, 2020 - mdpi.com
Carnitine can be considered a conditionally essential nutrient for its importance in human
physiology. This paper provides an updated picture of the main features of carnitine …
physiology. This paper provides an updated picture of the main features of carnitine …
Cardiovascular effects of performance-enhancing drugs
A La Gerche, MJ Brosnan - Circulation, 2017 - Am Heart Assoc
Exercise and competitive sports should be associated with a wide range of health benefits
with the potential to inspire a positive community health legacy. However, the reputation of …
with the potential to inspire a positive community health legacy. However, the reputation of …
Cardiotoxicity linked to anticancer agents and cardioprotective strategy
Chemotherapy is a main treatment for cancer, and it benefits patients by controlling cancer
relapse and metastasis, thereby leading to an increase in the overall survival rate. However …
relapse and metastasis, thereby leading to an increase in the overall survival rate. However …
Precision cardio-oncology: a systems-based perspective on cardiotoxicity of tyrosine kinase inhibitors and immune checkpoint inhibitors
SA Brown, JC Ray, J Herrmann - Journal of cardiovascular translational …, 2020 - Springer
Cancer therapies have been evolving from conventional chemotherapeutics to targeted
agents. This has fulfilled the hope of greater efficacy but unfortunately not of greater safety …
agents. This has fulfilled the hope of greater efficacy but unfortunately not of greater safety …